$DOX

Amdocs (DOX) Stock Looks Like A Bargain On Earnings

Amdocs (DOX) stock has fallen 26% year-to-date, raising questions about its valuation. The company's P/E ratio of 13.6x is below industry and peer averages, suggesting a discount. Recent deals highlight a focus on its aOS and AI software platform, which may influence earnings growth. Analysts debate whether the current price reflects fair value.

Original reporting
Published Oct 14, 2026, 11:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 12:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amdocs (DOX) Stock Looks Like A Bargain On Earnings — source image
Decision brief

The 30-second read

$DOXBullishLow
01

Why it matters

The analysis suggests a possible re‑rating of the stock but provides no new corporate event.

02

Market read

Valuation commentary only; no fresh corporate data to drive immediate trading decisions.

03

What to watch

Potential integration challenges and competitive pressure from larger cloud providers are not addressed.

Relevance 4/10Novelty 2/10Timing: none

Background

Amdocs has fallen 26% YTD; the article uses valuation metrics to argue the stock is a bargain.

Company-level read

Ticker impact

$DOXBullishMedium confidence
Context

Article evaluates Amdocs' recent 10‑year VEON agreement and Vubiquity sale and argues the stock is undervalued based on its P/E gap.

Expected impact

potential upside as the market prices in the perceived earnings bargain

Evidence & confidence

The piece highlights a 26% YTD decline and a 13.6x P/E versus industry averages, suggesting room for a re‑rating.

Market effects

May prompt broader IT services sector re‑valuation if Amdocs' valuation argument gains traction.

Limited to U.S. and global software markets; no immediate regional effect.

Low; article is company‑specific without macro implications.

Counterpoint

Investors could argue the stock is already fully discounted given execution risks of the VEON deal and Vubiquity divestiture.

Key entities

  • Amdocs

    U.S.-listed software and services provider (ticker DOX).

  • VEON

    Telecom group signing a 10‑year agreement with Amdocs.

  • Vubiquity

    Business unit sold by Amdocs.

Related articles

$DOXMedAI 8/10

Amdocs (DOX) Q3 2026 Earnings Call Transcript

Amdocs (DOX) reported Q3 FY2026 revenue of $1.175B, up 2.2% in constant currency, and non-GAAP diluted EPS of $1.84. Non-GAAP operating margin was 21.6%. Managed services revenue was $791M and 12-month backlog $4.26B. Full-year guidance: revenue 2.6% to 3.4% (midpoint 3%), non-GAAP EPS growth midpoint 6%, free cash flow $710M to $730M. A $0.91/share restructuring charge drove GAAP EPS to $0.59.

$DOXMedAI 8/10

AMDOCS LTD (DOX): Financial results for Q3 2026

AMDOCS LTD (DOX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Amdocs Limited Reports Third Quarter Fiscal 2026 Results Revenue of $1.17 Billion, up 2.7% YoY as Reported and up 2.2% YoY in Constant Currency (1) Expects Fiscal 2026 Revenue Growth Outlook of 3.2%-4.0% YoY as Reported Reiterates Midpoint of Fiscal 2026 Revenue Grow

$DOXMedAI 8/10

Amdocs Limited Reports Third Quarter Fiscal 2026 Results

Amdocs (NASDAQ:DOX) reported Q3 fiscal 2026 revenue of $1.175B, up 2.7% YoY as reported and 2.2% in constant currency. Managed services revenue was $791M (about 67%). GAAP diluted EPS was $0.59 and non-GAAP diluted EPS $1.84. It expects FY2026 revenue growth of 3.2% to 4.0% (reported) and signed a 10-year partnership with Liberty Latin America.